Genome & Company (KOSDAQ: 314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,555.00
-145.00 (-3.92%)
Sep 11, 2024, 2:59 PM KST

Genome & Company Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
106,998176,209245,897468,8271,048,465323,319
Market Cap Growth
-48.25%-28.34%-47.55%-55.28%224.28%-
Enterprise Value
104,390151,242185,907383,8411,026,945-
Last Close Price
3500.006245.008725.0017350.0039750.0019650.00
PE Ratio
--3.72-4.74-13.67-24.91-3.72
PS Ratio
4.2012.3317.461038.966962.787054.22
PB Ratio
0.911.551.634.139.11-8.51
P/FCF Ratio
-3.47-3.45-4.88-16.15-53.33-30.12
P/OCF Ratio
-6.68-5.47-5.65-17.92-57.74-32.18
EV/Sales Ratio
4.3610.5813.20850.636819.87-
EV/EBITDA Ratio
-3.73-3.23-3.87-11.46-40.81-
EV/EBIT Ratio
-3.02-2.75-3.23-10.64-38.57-
EV/FCF Ratio
-2.87-2.96-3.69-13.22-52.23-
Debt / Equity Ratio
0.250.230.040.060.02-0.19
Debt / FCF Ratio
-0.76-0.52-0.12-0.24-0.09-0.69
Asset Turnover
0.140.090.090.000.00-
Inventory Turnover
2.903.524.76---
Quick Ratio
3.483.169.838.0336.890.47
Current Ratio
3.753.4410.498.3237.000.48
Return on Equity (ROE)
-32.39%-38.36%-43.15%-31.52%-80.89%-
Return on Assets (ROA)
-15.59%-20.55%-23.17%-17.48%-21.33%-
Return on Capital (ROIC)
-18.08%-23.20%-25.95%-19.03%-38.58%-
Earnings Yield
-37.69%-26.94%-21.08%-7.28%-2.93%-26.19%
FCF Yield
-34.01%-28.99%-20.50%-6.19%-1.88%-3.32%
Buyback Yield / Dilution
-35.97%-0.32%-4.71%-39.60%-20.11%-
Total Shareholder Return
-35.97%-0.32%-4.71%-39.60%-20.11%-
Source: S&P Capital IQ. Standard template. Financial Sources.